Free Trial

BioXcel Therapeutics (BTAI) Short Interest Ratio & Short Volume

BioXcel Therapeutics logo
$3.70 -0.53 (-12.53%)
As of 01:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BioXcel Therapeutics Short Interest Data

BioXcel Therapeutics (BTAI) has a short interest of 1.52 million shares, representing 11.51% of the float (the number of shares available for trading by the public). This marks a 472.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 5.20 million shares to cover all short positions.

Current Short Interest
1,520,000 shares
Previous Short Interest
265,500 shares
Change Vs. Previous Month
+472.50%
Dollar Volume Sold Short
$8.33 million
Short Interest Ratio
0.2 Days to Cover
Last Record Date
August 15, 2025
Outstanding Shares
16,010,000 shares
Float Size
13,210,000 shares
Short Percent of Float
11.51%
Today's Trading Volume
1,602,471 shares
Average Trading Volume
5,195,510 shares
Today's Volume Vs. Average
31%
Short Selling BioXcel Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for BioXcel Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

BTAI Short Interest Over Time

BTAI Days to Cover Over Time

BTAI Percentage of Float Shorted Over Time

BioXcel Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/20251,520,000 shares $8.33 million +472.5%11.5%0.2 $5.48
7/31/2025265,500 shares $347.81 thousand -24.6%4.8%0 $1.31
7/15/2025352,200 shares $669.18 thousand +4.7%6.4%1.1 $1.90
6/30/2025336,400 shares $608.88 thousand +5.9%6.1%1.3 $1.81
6/15/2025317,600 shares $495.46 thousand -38.4%5.7%1.3 $1.56
5/31/2025515,700 shares $608.53 thousand +285.4%9.3%1.5 $1.18
5/15/2025133,800 shares $195.35 thousand +52.1%2.4%0 $1.46
4/30/202588,000 shares $162.80 thousand +18.4%1.9%0 $1.85
4/15/202574,300 shares $135.23 thousand -66.6%1.6%0 $1.82
3/31/2025222,700 shares $452.08 thousand +0.6%4.9%0.1 $2.03
3/15/2025221,300 shares $471.37 thousand -33.0%8.1%0.1 $2.13
2/28/2025330,500 shares $713.88 thousand +16.2%12.1%0.1 $2.16
2/15/2025284,500 shares $657.20 thousand +13.5%11.0%2 $2.31
1/31/2025250,700 shares $1.31 million -84.3%9.7%2.1 $5.22
1/15/20251,600,000 shares $554.40 thousand +98.1%N/A1.1 $0.35
12/31/2024807,700 shares $302.00 thousand -23.1%N/A1 $0.37
12/15/20241,050,000 shares $432.71 thousand +16.8%N/A1.7 $0.41
11/30/2024898,700 shares $367.30 thousand +44.0%N/A1.4 $0.41
11/15/2024624,100 shares $354.68 thousand +79.8%N/A1.2 $0.57
10/31/2024347,100 shares $231.45 thousand -39.8%N/A0.7 $0.67
10/15/2024576,400 shares $327.91 thousand +11.6%N/A1.2 $0.57
9/30/2024516,400 shares $315.00 thousand -26.0%N/A0.9 $0.61
9/15/2024697,600 shares $474.37 thousand +2.5%N/A1.1 $0.68
8/31/2024680,500 shares $418.51 thousand -6.9%N/A1.2 $0.62
8/15/2024731,200 shares $497.22 thousand -9.4%N/A1.2 $0.68
7/31/2024807,300 shares $904.18 thousand +28.9%N/A1.2 $1.12
7/15/2024626,100 shares $763.84 thousand -61.4%N/A1 $1.22
6/30/20241,620,000 shares $2.07 million +8.7%N/A2.8 $1.28
6/15/20241,490,000 shares $2.04 million +0.7%N/A2.9 $1.37
5/31/20241,480,000 shares $2.68 million -9.2%N/A2.6 $1.81
5/15/20241,630,000 shares $3.36 million +8.7%N/A2.8 $2.06
4/30/20241,500,000 shares $3.78 million -28.2%N/A1 $2.52
4/15/20242,090,000 shares $5.75 million -16.1%N/A1.4 $2.75
3/31/20242,490,000 shares $7.02 million -20.7%10.5%1.7 $2.82
3/15/20243,140,000 shares $8.42 million -20.9%14.6%2.1 $2.68
2/29/20243,970,000 shares $12.62 million -46.8%18.7%2.6 $3.18
2/15/20247,460,000 shares $26.78 million +203.3%35.2%4.9 $3.59
1/31/20242,460,000 shares $7.92 million -17.5%11.9%2.1 $3.22
1/15/20242,980,000 shares $7.84 million +0.3%14.4%1.1 $2.63
12/31/20232,970,000 shares $8.76 million +3.5%14.7%1 $2.95
12/15/20232,870,000 shares $9.30 million -16.6%14.2%0.9 $3.24
11/30/20233,440,000 shares $13.07 million -32.3%17.0%1.1 $3.80
11/15/20235,080,000 shares $22.35 million -12.6%25.1%1.6 $4.40
10/31/20235,810,000 shares $23.33 million +16.9%28.8%1.9 $4.02
10/15/20234,970,000 shares $15.56 million +38.8%24.6%3.6 $3.13
9/30/20233,580,000 shares $9.06 million -24.6%17.7%2.4 $2.53
9/15/20234,750,000 shares $15.87 million +8.0%23.5%1.6 $3.34
8/31/20234,400,000 shares $16.63 million -34.8%21.8%1.5 $3.78
8/15/20236,750,000 shares $27.95 million -4.1%33.5%2.3 $4.14
7/31/20237,040,000 shares $64.35 million -18.8%35.0%2.7 $9.14
7/15/20238,670,000 shares $89.30 million +69.0%43.1%3.5 $10.30
6/30/20235,130,000 shares $34.17 million +12.3%25.5%2.2 $6.66
6/15/20234,570,000 shares $98.26 million +22.9%22.7%8.3 $21.50
5/31/20233,720,000 shares $66.74 million +11.0%18.5%6.2 $17.94
5/15/20233,350,000 shares $91.22 million -5.4%16.7%6.5 $27.23
4/30/20233,540,000 shares $72.99 million -5.1%17.7%6.9 $20.62
4/15/20233,730,000 shares $69.90 million +3.6%18.6%7.4 $18.74
3/31/20233,600,000 shares $67.18 million +21.2%18.3%7.2 $18.66
3/15/20232,970,000 shares $58.21 million +5.7%15.1%6.3 $19.60
2/28/20232,810,000 shares $89.70 million +8.9%14.7%8 $31.92
2/15/20232,580,000 shares $84.29 million +5.3%13.5%7.6 $32.67
1/31/20232,450,000 shares $69.87 million +5.6%12.9%7.4 $28.52
1/15/20232,320,000 shares $67.14 million -3.3%12.2%8.1 $28.94
12/30/20222,400,000 shares $51.55 million +10.1%12.6%9.4 $21.48
12/15/20222,180,000 shares $44.04 million -4.4%11.5%9 $20.20
11/30/20222,280,000 shares $37.78 million -3.4%12.0%10.2 $16.57
11/15/20222,360,000 shares $38.00 million -6.7%12.4%10.9 $16.10
10/31/20222,530,000 shares $31.85 million -4.2%13.3%11.7 $12.59
10/15/20222,640,000 shares $27.06 million -5.7%13.9%11.1 $10.25
9/30/20222,800,000 shares $33.10 million -2.1%14.7%10.4 $11.82
9/15/20222,860,000 shares $37.95 million -2.4%15.0%8.5 $13.27
8/31/20222,930,000 shares $40.08 million -0.3%15.4%6.9 $13.68
8/15/20222,940,000 shares $44.86 million +7.7%15.5%6.1 $15.26
7/31/20222,730,000 shares $42.15 million -5.5%14.4%5 $15.44
7/15/20222,890,000 shares $48.70 million -19.7%15.2%5 $16.85
6/30/20223,600,000 shares $47.52 million -9.3%19.0%4 $13.20
6/15/20223,970,000 shares $39.14 million -1.2%20.9%4.4 $9.86
5/31/20224,020,000 shares $47.03 million -2.9%21.2%4.8 $11.70
5/15/20224,140,000 shares $48.60 million +5.3%21.8%5.2 $11.74
4/30/20223,930,000 shares $51.52 million -3.0%20.7%5.3 $13.11
4/15/20224,050,000 shares $63.10 million +97.6%21.4%5.7 $15.58
3/31/20222,050,000 shares $42.87 million +9.0%10.8%3.3 $20.91
3/15/20221,880,000 shares $28.31 million +0.5%9.9%6.1 $15.06
2/28/20221,870,000 shares $34.24 million +10.7%9.9%6.5 $18.31
2/15/20221,690,000 shares $31.38 million -5.1%8.9%5.4 $18.57
1/31/20221,780,000 shares $30.08 million -0.6%9.4%5.5 $16.90
1/15/20221,790,000 shares $34.91 million +3.5%9.4%5.9 $19.50
12/31/20211,730,000 shares $35.17 million -11.7%9.1%5.7 $20.33
12/15/20211,960,000 shares $42.59 million -1.0%10.3%6.7 $21.73
11/30/20211,980,000 shares $45.40 million +10.6%10.4%6.9 $22.93
11/15/20211,790,000 shares $48.71 million -4.3%9.4%6.6 $27.21
10/29/20211,870,000 shares $54.49 million +8.1%9.9%7.5 $29.14
10/15/20211,730,000 shares $46.87 million -6.0%9.1%6.7 $27.09
9/30/20211,840,000 shares $55.84 million -3.2%9.7%6.9 $30.35
9/15/20211,900,000 shares $56.51 million -6.9%10.0%5.4 $29.74
8/31/20212,040,000 shares $60.08 million -8.1%10.8%5.4 $29.45
8/13/20212,220,000 shares $54.59 million -5.9%11.8%5.9 $24.59
7/30/20212,360,000 shares $60.39 million -9.9%12.6%6.1 $25.59
7/15/20212,620,000 shares $70.11 million -11.8%14.0%6.8 $26.76
6/30/20212,970,000 shares $86.31 million +2.1%16.9%7.7 $29.06
6/15/20212,910,000 shares $108.60 million -5.5%19.2%7.8 $37.32
5/28/20213,080,000 shares $101.73 million -3.1%20.3%7.8 $33.03
5/14/20213,180,000 shares $96.67 million -5.6%21.0%7.3 $30.40
4/30/20213,370,000 shares $116.27 million -7.7%22.3%7.1 $34.50
4/15/20213,650,000 shares $127.57 million +9.0%N/A7 $34.95
3/31/20213,350,000 shares $137.69 million -9.7%21.4%6.1 $41.10
3/15/20213,710,000 shares $174.33 million +2.8%23.8%6.5 $46.99
2/26/20213,610,000 shares $199.09 million +1.1%23.4%6.7 $55.15
2/12/20213,570,000 shares $230.62 million +5.6%23.1%6.8 $64.60
1/29/20213,380,000 shares $156.33 million -7.9%23.0%6.6 $46.25
1/15/20213,670,000 shares $198.55 million +10.2%25.0%7.7 $54.10
12/31/20203,330,000 shares $163.90 million +4.4%22.7%6.9 $49.22
12/15/20203,190,000 shares $147.89 million -2.5%21.8%7.2 $46.36
11/30/20203,270,000 shares $145.81 million +10.9%22.3%7.2 $44.59
11/15/20202,950,000 shares $160.13 million +4.2%20.1%6.2 $54.28
10/30/20202,830,000 shares $133.15 million +22.0%22.4%5.2 $47.05
10/15/20202,320,000 shares $120.41 million -13.8%18.3%3.5 $51.90
9/30/20202,690,000 shares $116.64 million +17.0%21.3%3.9 $43.36
9/15/20202,300,000 shares $111.09 million +6.5%18.2%3.3 $48.30

BTAI Short Interest - Frequently Asked Questions

What is BioXcel Therapeutics' current short interest?

Short interest is the volume of BioXcel Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 1,520,000 shares of BTAI short. 11.51% of BioXcel Therapeutics' shares are currently sold short. Learn More on BioXcel Therapeutics' current short interest.

Which institutional investors are shorting BioXcel Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioXcel Therapeutics: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for BioXcel Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.51% of BioXcel Therapeutics' floating shares are currently sold short.

Is BioXcel Therapeutics' short interest increasing or decreasing?

BioXcel Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 1,520,000 shares, an increase of 472.5% from the previous total of 265,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioXcel Therapeutics' float size?

BioXcel Therapeutics currently has issued a total of 16,010,000 shares. Some of BioXcel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioXcel Therapeutics currently has a public float of 13,210,000 shares.

How does BioXcel Therapeutics' short interest compare to its competitors?

11.51% of BioXcel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioXcel Therapeutics: Prima BioMed Ltd (2.88%), Annexon, Inc. (8.98%), Voyager Therapeutics, Inc. (5.35%), Lyell Immunopharma, Inc. (2.41%), Alpha Teknova, Inc. (26.11%), Tonix Pharmaceuticals Holding Corp. (15.41%), Sagimet Biosciences Inc. (10.73%), AC Immune (2.44%), Aclaris Therapeutics, Inc. (5.52%), Humacyte, Inc. (26.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

What does it mean to sell short BioXcel Therapeutics stock?

Short selling BTAI is an investing strategy that aims to generate trading profit from BioXcel Therapeutics as its price is falling. BTAI shares are trading down $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioXcel Therapeutics?

A short squeeze for BioXcel Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BTAI, which in turn drives the price of the stock up even further.

How often is BioXcel Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTAI, twice per month. The most recent reporting period available is August, 15 2025.




This page (NASDAQ:BTAI) was last updated on 9/9/2025 by MarketBeat.com Staff
From Our Partners